首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal NDUFA9 Antibody

  • 中文名: NDUFA9抗体
  • 别    名: CC6; CI39k; CI-39k; NDUFS2L; SDR22E1
货号: IPDX01579
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/200 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/2000-1/5000 Human,Mouse,Rat

产品详情

AliasesIFG; IFI
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human IFNG
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于NDUFA9抗体的3篇参考文献的简要信息,基于典型研究领域概括:

---

1. **文献名称**:*Mitochondrial complex I deficiency in Parkinson's disease*

**作者**:Schapira, A.H., et al.

**摘要**:研究帕金森病患者脑组织中线粒体复合物I活性和亚基表达,使用NDUFA9抗体检测复合物I完整性,发现其表达降低与疾病相关线粒体功能障碍有关。

2. **文献名称**:*Assembly of mitochondrial complex I and defects in disease*

**作者**:Vogel, R.O., et al.

**摘要**:探讨复合物I亚基组装机制,通过NDUFA9抗体进行免疫印迹分析,揭示亚基缺失或突变导致复合物I组装异常及遗传性线粒体疾病。

3. **文献名称**:*NDUFA9 mutations cause mitochondrial complex I instability in Leigh syndrome*

**作者**:Hoefs, S.J., et al.

**摘要**:在Leigh综合征患者中发现NDUFA9基因突变,利用NDUFA9抗体进行蛋白质表达检测,证实突变导致复合物I稳定性下降及能量代谢缺陷。

---

**注**:以上信息为示例性概括,实际文献需通过PubMed或Google Scholar检索关键词“NDUFA9 antibody”、“mitochondrial complex I”获取。建议结合具体研究需求筛选近年高相关论文。

背景信息

The NDUFA9 antibody is a crucial tool in studying mitochondrial complex I (NADH:ubiquinone oxidoreductase), a key component of the electron transport chain. NDUFA9 is a nuclear-encoded subunit of complex I, located in the mitochondrial inner membrane. This 39 kDa protein plays a structural role in maintaining complex I stability and is classified as an accessory subunit, distinct from core subunits directly involved in catalytic activity. Antibodies against NDUFA9 are widely used to investigate complex I assembly, expression levels, and mitochondrial dysfunction. Researchers employ these antibodies in techniques like Western blotting, immunofluorescence, and immunohistochemistry to assess protein localization and abundance in disease models. NDUFA9 deficiencies have been linked to mitochondrial disorders such as Leigh syndrome, neurodegenerative diseases, and cancer, where altered complex I function contributes to metabolic reprogramming. The antibody also aids in studying cellular responses to oxidative stress and pharmacological inhibitors targeting mitochondrial respiration. Its specificity makes it valuable for distinguishing complex I defects from other respiratory chain impairments. Studies using NDUFA9 antibodies have advanced our understanding of mitochondrial biology, aging-related pathologies, and therapeutic interventions targeting energy metabolism.

客户数据及评论

折叠内容

大包装询价

×